{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:18:28Z","timestamp":1789442308982,"version":"build-2803163510"},"reference-count":54,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science","award":["2022-I2M-1-018"],"award-info":[{"award-number":["2022-I2M-1-018"]}]},{"name":"Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science","award":["2021-I2M-1-022"],"award-info":[{"award-number":["2021-I2M-1-022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>In this study, we designed and developed a DOX nanodrug delivery system (PEG-GA@ZIF-8@DOX) using ZIF-8 as the carrier and glycyrrhetinic acid (GA) as the targeting ligand. We confirmed that DOX was loaded and PEG-GA was successfully modified on the surface of the nanoparticles. The in vitro release profile of the system was investigated at pH 5.0 and 7.4. The cellular uptake, in vitro cytotoxicity, and lysosomal escape characteristics were examined using HepG2 cells. We established an H22 tumor-bearing mouse model and evaluated the in vivo antitumor activity. The results showed that the system had a uniform nanomorphology. The drug loading capacity was 11.22 \u00b1 0.87%. In acidic conditions (pH 5.0), the final release rate of DOX was 57.73%, while at pH 7.4, it was 25.12%. GA-mediated targeting facilitated the uptake of DOX by the HepG2 cells. PEG-GA@ZIF-8@DOX could escape from the lysosomes and release the drug in the cytoplasm, thus exerting its antitumor effect. When the in vivo efficacy was analyzed, we found that the tumor inhibition rate of PEG-GA@ZIF-8@DOX was 67.64%; it also alleviated the loss of the body weight of the treated mice. This drug delivery system significantly enhanced the antitumor effect of doxorubicin in vitro and in vivo, while mitigating its toxic side effects.<\/jats:p>","DOI":"10.3390\/molecules28248131","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T11:28:07Z","timestamp":1702898887000},"page":"8131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment"],"prefix":"10.3390","volume":"28","author":[{"given":"Xiao","family":"Mi","sequence":"first","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9088-7984","authenticated-orcid":false,"given":"Yang","family":"Lou","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingran","family":"Dong","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Xue","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lu","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7635-0451","authenticated-orcid":false,"given":"Xi","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Anwanwan, D., Singh, S.K., Singh, S., Saikam, V., and Singh, R. (2020). Challenges in liver cancer and possible treatment approaches. Biochim. Biophys. Acta Rev. Cancer, 1873.","DOI":"10.1016\/j.bbcan.2019.188314"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Speciale, A., Muscar\u00e0, C., Molonia, M.S., Cristani, M., Cimino, F., and Saija, A. (2022). Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy. Molecules, 27.","DOI":"10.3390\/molecules27061775"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acsami.7b14705","article-title":"Porous Au@Pt Nanoparticles: Therapeutic Platform for Tumor Chemo-Photothermal Co-Therapy and Alleviating Doxorubicin-Induced Oxidative Damage","volume":"10","author":"Yang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_6","first-page":"2993","article-title":"Recent progress in treatment of hepatocellular carcinoma","volume":"10","author":"Chen","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"16630","DOI":"10.3748\/wjg.v20.i44.16630","article-title":"Advances in non-surgical management of primary liver cancer","volume":"20","author":"Chen","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.lfs.2017.07.032","article-title":"Binding effect of fluorescence labeled glycyrrhetinic acid with GA receptors in hepatocellular carcinoma cells","volume":"188","author":"Sun","year":"2017","journal-title":"Life Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1166\/jbn.2018.2638","article-title":"Glycyrrhetinic Acid Functionalized Nanoparticles for Drug Delivery to Liver Cancer","volume":"14","author":"Wu","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/acs.molpharmaceut.5b00677","article-title":"Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy","volume":"13","author":"Cai","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: Progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00257622","article-title":"Comparison of the intracellular pharmacokinetics of doxorubicin and 4\u2032-epi-doxorubicin in patients with acute leukemia","volume":"24","author":"Tidefelt","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MPH.0b013e3182427593","article-title":"FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients","volume":"34","author":"Quarello","year":"2012","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2018.09.018","article-title":"Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging","volume":"289","author":"Etrych","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3892\/ijo.2016.3558","article-title":"Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines","volume":"49","author":"Calaf","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/2211-5463.13330","article-title":"Doxorubicin promotes breast cancer cell migration and invasion via DCAF13","volume":"12","author":"Sun","year":"2022","journal-title":"FEBS Open Bio"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2147\/DDDT.S198003","article-title":"Lung cancer combination therapy: Doxorubicin and \u03b2-elemene co-loaded, pH-sensitive nanostructured lipid carriers","volume":"13","author":"Cao","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Radu, E.R., Semenescu, A., and Voicu, S.I. (2022). Recent Advances in Stimuli-Responsive Doxorubicin Delivery Systems for Liver Cancer Therapy. Polymers, 14.","DOI":"10.3390\/polym14235249"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1166\/jnn.2021.19347","article-title":"Preparation of Epidermal Growth Factor-Modified Targeted Doxorubicin Nanoliposomes and Therapy of Liver Cancer","volume":"21","author":"Chen","year":"2021","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3892\/or.2021.7983","article-title":"Kaempferol exhibits a synergistic effect with doxorubicin to inhibit proliferation, migration, and invasion of liver cancer","volume":"45","author":"Yang","year":"2021","journal-title":"Oncol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.apsb.2020.02.002","article-title":"Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer","volume":"10","author":"Kuerban","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.2147\/IJN.S359642","article-title":"An Acid-Sensitive Nanofiber Conjugate Based on a Short Aromatic Peptide for Targeted Delivery of Doxorubicin in Liver Cancer","volume":"17","author":"Liang","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2018.1556359","article-title":"Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma","volume":"26","author":"Xia","year":"2019","journal-title":"Drug Deliv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.actbio.2019.05.034","article-title":"Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo","volume":"92","author":"Wei","year":"2019","journal-title":"Acta Biomater."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.7150\/thno.68456","article-title":"A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma","volume":"12","author":"He","year":"2022","journal-title":"Theranostics"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Alshawwa, S.Z., Kassem, A.A., Farid, R.M., Mostafa, S.K., and Labib, G.S. (2022). Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040883"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Chatterjee, S., Harini, K., Girigoswami, A., Nag, M., Lahiri, D., and Girigoswami, K. (2022). Nanodecoys: A Quintessential Candidate to Augment Theranostic Applications for a Plethora of Diseases. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics15010073"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"19808","DOI":"10.1038\/s41598-021-99407-5","article-title":"Dual-ligated metal organic framework as novel multifunctional nanovehicle for targeted drug delivery for hepatic cancer treatment","volume":"11","author":"Fytory","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"214262","DOI":"10.1016\/j.ccr.2021.214262","article-title":"Application of MOF materials as drug delivery systems for cancer therapy and dermal treatment","volume":"451","author":"Mallakpour","year":"2022","journal-title":"Coordin. Chem. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20678","DOI":"10.1021\/acsami.9b04236","article-title":"Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy","volume":"7","author":"Ren","year":"2019","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Xie, H., Liu, X., Huang, Z., Xu, L., Bai, R., He, F., Wang, M., Han, L., Bao, Z., and Wu, Y. (2022). Nanoscale Zeolitic Imidazolate Framework (ZIF)-8 in Cancer Theranostics: Current Challenges and Prospects. Cancers, 8.","DOI":"10.3390\/cancers14163935"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1600818","DOI":"10.1002\/adhm.201600818","article-title":"Validating Metal-Organic Framework Nanoparticles for Their Nanosafety in Diverse Biomedical Applications","volume":"6","author":"Wuttke","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1021\/jacs.8b04457","article-title":"Biomineralized Metal-Organic Framework Nanoparticles Enable Intracellular Delivery and Endo-Lysosomal Release of Native Active Proteins","volume":"140","author":"Chen","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14113","DOI":"10.1039\/C6CC07321B","article-title":"A drug-loaded nanoscale metal-organic framework with a tumor targeting agent for highly effective hepatoma therapy","volume":"52","author":"Li","year":"2016","journal-title":"Chem. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1021\/jacs.5b11720","article-title":"One-pot Synthesis of Metal-Organic Frameworks with Encapsulated Target Molecules and Their Applications for Controlled Drug Delivery","volume":"138","author":"Zheng","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.2147\/IJN.S340764","article-title":"Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy","volume":"16","author":"Mi","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"19687","DOI":"10.1021\/acsami.7b05142","article-title":"Rational Design of Metal Organic Framework Nanocarrier-Based Codelivery System of Doxorubicin Hydrochloride\/Verapamil Hydrochloride for Overcoming Multidrug Resistance with Efficient Targeted Cancer Therapy","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41551-021-00701-4","article-title":"Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion-drug conjugates with cell-membrane affinity","volume":"5","author":"Chen","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"31998","DOI":"10.1021\/acsami.8b11972","article-title":"Metal-Organic Framework-Based Nanoplatform for Intracellular Environment-Responsive Endo\/Lysosomal Escape and Enhanced Cancer Therapy","volume":"10","author":"Dong","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Syahputra, R.A., Harahap, U., Dalimunthe, A., Nasution, M.P., and Satria, D. (2022). The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review. Molecules, 27.","DOI":"10.3390\/molecules27041320"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.msec.2016.12.134","article-title":"Role of generation on folic acid-modified poly(amidoamine) dendrimers for targeted delivery of baicalin to cancer cells","volume":"75","author":"Lv","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1703306","DOI":"10.1002\/smll.201703306","article-title":"Glycyrrhetinic Acid Functionalized Graphene Oxide for Mitochondria Targeting and Cancer Treatment In Vivo","volume":"14","author":"Zhang","year":"2018","journal-title":"Small"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1080\/10717544.2021.1983077","article-title":"In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor","volume":"28","author":"Sun","year":"2021","journal-title":"Drug Deliv."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2017.01.042","article-title":"Tumor-targeted pH\/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery","volume":"259","author":"Chen","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1158\/1535-7163.MCT-17-0134","article-title":"Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR","volume":"16","author":"Muralidharan","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2010.06.029","article-title":"Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery","volume":"397","author":"He","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.actbio.2010.04.021","article-title":"Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl l-glutamate) micelles for liver targeting therapy","volume":"6","author":"Huang","year":"2010","journal-title":"Acta Biomater."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"325602","DOI":"10.1088\/1361-6528\/ab8c03","article-title":"Glycyrrhetinic acid modified MOFs for the treatment of liver cancer","volume":"31","author":"Li","year":"2020","journal-title":"Nanotechnology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2020.06.017","article-title":"Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma","volume":"489","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2017.02.010","article-title":"Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting","volume":"520","author":"Liu","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1039\/C8BM00625C","article-title":"FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor","volume":"6","author":"Shi","year":"2018","journal-title":"Biomater. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10534-010-9302-8","article-title":"Zinc pyrithione induces cellular stress signaling and apoptosis in Hep-2 cervical tumor cells: The role of mitochondria and lysosomes","volume":"23","author":"Rudolf","year":"2010","journal-title":"Biometals"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/acs.molpharmaceut.2c00842","article-title":"Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy","volume":"20","author":"Qiu","year":"2023","journal-title":"Mol. Pharm."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/24\/8131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:40:06Z","timestamp":1760132406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/24\/8131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":54,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["molecules28248131"],"URL":"https:\/\/doi.org\/10.3390\/molecules28248131","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,16]]}}}